Biomarin Pharmaceutical (BMRN)'s 30-day implied volatility (IV30) was 27.5% at the close on October 28, 2026, down from 33.0% the day before, against a 52-week range of 19.3% to 55.5%. Its 20-day historical volatility was 30.4%.
Data as of October 28, 2026.